Dolika D Vasović, Dejan M Rašić, Jelica Pantelić, Bojana Dačić-Krnjaja, Tanja Kalezić, Jelena Vasilijević, Igor Kovačević, Ivan Marjanović
{"title":"儿童b细胞前体急性淋巴母细胞白血病孤立性前段复发:一例罕见病例报告。","authors":"Dolika D Vasović, Dejan M Rašić, Jelica Pantelić, Bojana Dačić-Krnjaja, Tanja Kalezić, Jelena Vasilijević, Igor Kovačević, Ivan Marjanović","doi":"10.1097/MPH.0000000000003117","DOIUrl":null,"url":null,"abstract":"<p><p>Ocular relapse in pediatric acute lymphoblastic leukemia (ALL) is rare and typically associated with central nervous system or bone marrow involvement. Anterior segment infiltration as the sole manifestation of relapse is exceptionally uncommon and may mimic noninfectious uveitis, leading to diagnostic delay. We report the case of a 4-year-old boy with a history of B-cell precursor ALL, diagnosed at age 2 and treated according to the ALL IC BFM 2009 protocol. The patient remained in remission until presenting with persistent redness and irritation of the left eye, unresponsive to topical corticosteroids and cycloplegics. Slit-lamp examination revealed sectoral iris thickening, which was further assessed using ultrasound biomicroscopy and confirmed localized stromal infiltration without ciliary body involvement. The posterior segment was unremarkable. Initial systemic reevaluation showed no evidence of hematologic or CNS relapse, and at that time, ocular findings were provisionally considered an isolated recurrence. However, ∼3 months after the onset of ocular symptoms, the patient exhibited hematologic abnormalities, and relapse was confirmed with 31% circulating blasts, thrombocytopenia, and 92% blasts in bone marrow aspirate. He was subsequently reclassified as high-risk and systemic therapy was resumed. This case illustrates a rare presentation of anterior segment involvement as the initial manifestation of relapse in pediatric ALL. Clinicians should maintain a high index of suspicion when evaluating persistent or atypical anterior uveitis in leukemia survivors, as early recognition of ocular involvement may be critical for timely diagnosis and treatment of systemic recurrence.</p>","PeriodicalId":16693,"journal":{"name":"Journal of Pediatric Hematology/Oncology","volume":" ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Isolated Anterior Segment Relapse in a Child With B-Cell Precursor Acute Lymphoblastic Leukemia: A Rare Case Report.\",\"authors\":\"Dolika D Vasović, Dejan M Rašić, Jelica Pantelić, Bojana Dačić-Krnjaja, Tanja Kalezić, Jelena Vasilijević, Igor Kovačević, Ivan Marjanović\",\"doi\":\"10.1097/MPH.0000000000003117\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Ocular relapse in pediatric acute lymphoblastic leukemia (ALL) is rare and typically associated with central nervous system or bone marrow involvement. Anterior segment infiltration as the sole manifestation of relapse is exceptionally uncommon and may mimic noninfectious uveitis, leading to diagnostic delay. We report the case of a 4-year-old boy with a history of B-cell precursor ALL, diagnosed at age 2 and treated according to the ALL IC BFM 2009 protocol. The patient remained in remission until presenting with persistent redness and irritation of the left eye, unresponsive to topical corticosteroids and cycloplegics. Slit-lamp examination revealed sectoral iris thickening, which was further assessed using ultrasound biomicroscopy and confirmed localized stromal infiltration without ciliary body involvement. The posterior segment was unremarkable. Initial systemic reevaluation showed no evidence of hematologic or CNS relapse, and at that time, ocular findings were provisionally considered an isolated recurrence. However, ∼3 months after the onset of ocular symptoms, the patient exhibited hematologic abnormalities, and relapse was confirmed with 31% circulating blasts, thrombocytopenia, and 92% blasts in bone marrow aspirate. He was subsequently reclassified as high-risk and systemic therapy was resumed. This case illustrates a rare presentation of anterior segment involvement as the initial manifestation of relapse in pediatric ALL. Clinicians should maintain a high index of suspicion when evaluating persistent or atypical anterior uveitis in leukemia survivors, as early recognition of ocular involvement may be critical for timely diagnosis and treatment of systemic recurrence.</p>\",\"PeriodicalId\":16693,\"journal\":{\"name\":\"Journal of Pediatric Hematology/Oncology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pediatric Hematology/Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MPH.0000000000003117\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Hematology/Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MPH.0000000000003117","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
小儿急性淋巴细胞白血病(ALL)的眼部复发是罕见的,通常与中枢神经系统或骨髓受累有关。前段浸润作为复发的唯一表现是非常罕见的,可能类似于非感染性葡萄膜炎,导致诊断延迟。我们报告一个4岁的男孩,有b细胞前体ALL病史,在2岁时诊断并根据ALL IC BFM 2009方案治疗。患者病情一直缓解,直到出现左眼持续红肿和刺激,对局部皮质类固醇无反应和睫状体麻痹。裂隙灯检查显示部门性虹膜增厚,超声生物显微镜进一步评估并确认局部间质浸润,未累及睫状体。后段不明显。最初的全身重新评估显示没有血液学或中枢神经系统复发的证据,当时,眼部的发现暂时被认为是孤立的复发。然而,在眼部症状出现3个月后,患者出现血液学异常,复发被证实为31%的循环母细胞、血小板减少症和92%的骨髓抽吸母细胞。随后,他被重新分类为高危人群,并恢复全身治疗。这个病例显示了一个罕见的前节段受累作为儿科ALL复发的初始表现。临床医生在评估白血病幸存者持续性或非典型前葡萄膜炎时应保持高度的怀疑指数,因为早期识别眼部受累可能对及时诊断和治疗全身复发至关重要。
Isolated Anterior Segment Relapse in a Child With B-Cell Precursor Acute Lymphoblastic Leukemia: A Rare Case Report.
Ocular relapse in pediatric acute lymphoblastic leukemia (ALL) is rare and typically associated with central nervous system or bone marrow involvement. Anterior segment infiltration as the sole manifestation of relapse is exceptionally uncommon and may mimic noninfectious uveitis, leading to diagnostic delay. We report the case of a 4-year-old boy with a history of B-cell precursor ALL, diagnosed at age 2 and treated according to the ALL IC BFM 2009 protocol. The patient remained in remission until presenting with persistent redness and irritation of the left eye, unresponsive to topical corticosteroids and cycloplegics. Slit-lamp examination revealed sectoral iris thickening, which was further assessed using ultrasound biomicroscopy and confirmed localized stromal infiltration without ciliary body involvement. The posterior segment was unremarkable. Initial systemic reevaluation showed no evidence of hematologic or CNS relapse, and at that time, ocular findings were provisionally considered an isolated recurrence. However, ∼3 months after the onset of ocular symptoms, the patient exhibited hematologic abnormalities, and relapse was confirmed with 31% circulating blasts, thrombocytopenia, and 92% blasts in bone marrow aspirate. He was subsequently reclassified as high-risk and systemic therapy was resumed. This case illustrates a rare presentation of anterior segment involvement as the initial manifestation of relapse in pediatric ALL. Clinicians should maintain a high index of suspicion when evaluating persistent or atypical anterior uveitis in leukemia survivors, as early recognition of ocular involvement may be critical for timely diagnosis and treatment of systemic recurrence.
期刊介绍:
Journal of Pediatric Hematology/Oncology (JPHO) reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. The journal publishes original research, commentaries, historical insights, and clinical and laboratory observations.